Published in Hum Genet on March 11, 2016
From Peas to Disease: Modifier Genes, Network Resilience, and the Genetics of Health. Am J Hum Genet (2017) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr (1990) 25.24
Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet (1996) 17.95
Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet (2006) 8.19
New approaches to population stratification in genome-wide association studies. Nat Rev Genet (2010) 7.97
Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol (1991) 7.93
Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol (2003) 6.99
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation (1995) 6.55
Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res (1996) 6.13
PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics (2005) 5.14
Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell (1994) 4.47
Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation (2000) 3.68
Betting odds and genetic associations. J Natl Cancer Inst (2004) 3.39
Power and design considerations for a general class of family-based association tests: quantitative traits. Am J Hum Genet (2002) 2.96
The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol (2001) 2.83
Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol (2014) 2.75
Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet (1993) 2.38
Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy. Circulation (2010) 2.15
Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ Res (2011) 1.58
Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol (2002) 1.47
Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation (1995) 1.26
Interpretation of genetic association studies in complex disease. Pharmacogenomics J (2002) 1.22
Genetic advances in sarcomeric cardiomyopathies: state of the art. Cardiovasc Res (2015) 1.19
The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. Am J Hum Genet (1999) 1.15
A tool for selecting SNPs for association studies based on observed linkage disequilibrium patterns. Pac Symp Biocomput (2006) 1.09
Improving the power of association tests for quantitative traits in family studies. Genet Epidemiol (2006) 1.03
A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. J Cardiovasc Med (Hagerstown) (2006) 1.01
Polymerase chain reaction-based detection of MN blood group-specific sequences in the human genome. Transfusion (1993) 0.94
Selecting single-nucleotide polymorphisms for association studies with SNPbrowser software. Methods Mol Biol (2007) 0.88
Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy. Cardiovasc Res (2007) 0.86
Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy. Hum Genet (2008) 0.83
Ascribing novel functions to the sarcomeric protein, myosin binding protein H (MyBPH) in cardiac sarcomere contraction. Exp Cell Res (2014) 0.79
Rare variants in genes encoding MuRF1 and MuRF2 are modifiers of hypertrophic cardiomyopathy. Int J Mol Sci (2014) 0.77